Navigation Links
Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
Date:10/16/2007

- NEXIUM(R) (esomeprazole magnesium) Proven Effective at Standard Doses

Regardless of Body Mass Index -

PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- The link between gastroesophageal reflux disease (GERD) and obesity has long been established, but healthcare professionals have had little guidance as to whether obese patients with GERD should be treated differently than normal-weight patients with GERD. Two studies about obesity and its relationship to GERD were presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting this week. One study, which evaluated symptom resolution in patients with non-erosive reflux disease, a type of GERD, received a 2007 ACG Presidential Poster Award. The other study examined GERD patients with erosive esophagitis, a condition in which stomach acid wears away, or erodes, the inner lining of the esophagus over time. Results of both studies showed despite whether a patient with GERD is considered obese or not, treatment should remain the same.(1)(2)

Body Mass Index (BMI) measures body fat by comparing a person's height to weight. A person with a BMI greater than 30 kg/m(2) is considered obese.(3) GERD is characterized by frequent, persistent heartburn (a burning feeling, rising from the stomach or lower part of the chest towards the neck) two or more days a week. It occurs when the valve between the esophagus and stomach does not close properly, allowing acid to leak back into the esophagus. When a person is overweight or obese, pressure inside the abdomen may increase causing this valve to relax, often leading to acid reflux.(3) In fact, studies have shown that people with a BMI greater than 30 kg/m(2) -- the cutoff for obesity -- face double the risk of developing GERD.(3)

"With obesity on the rise and more patients at risk for GERD than ever before, it's especially important that we understand how to treat overweight patients with GERD," said Prateek Sharma,
'/>"/>

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
4. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
5. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
10. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
11. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... N.J. , Sept. 19, 2014 Merck (NYSE: ... States and Canada , is teaming ... Desafiando La Diabetes: Logra Tus Metas , an educational program encouraging ... blood sugar -- a key treatment goal to help reduce the ... States are at a higher risk for developing type ...
(Date:9/19/2014)... R.I. , Sept. 19, 2014 Larry ... CVS ), will speak before the National Press ... will discuss the company,s recent move to stop selling tobacco ... shape the future of health. "Dramatic changes in ... health care providers and government," Merlo has said. "CVS Health ...
(Date:9/19/2014)... -- BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical ... ® in the U.S. and XIAPEX ® in ... , will present a corporate overview at the 21 st ... The presentation will take place on Friday, September ... Hotel in New York, NY . A ...
Breaking Medicine Technology:Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2
... , , LACHEN, Switzerland and HOBOKEN, N.J., ... m a AG is leading an ... therapy - anti-factor VIII (FVIII) antibodies, also known as inhibitors. This initiative, ... from a human cell line, could dramatically impact the treatment of an ...
... , , , ... AMGN ) today announced that in a large, randomized, double-blind, placebo-controlled, ... requiring dialysis), anemia and type-2 diabetes (the T rial to ... T herapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin ...
Cached Medicine Technology:Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies 2Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies 3Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies 4Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies 5Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 2Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 3Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 4Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 5Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 6Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 7Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 8
(Date:9/20/2014)... Ticket Down is a reputable ... her 2015 “Honeymoon Tour.” This well-known ticket exchange is ... , In early 2015, fans will have a chance to ... North America. Twenty-one-year-old Ariana Grande will hit the road in ... to 25 cities across the United States and Canada. Grande, ...
(Date:9/20/2014)... The excitement is building up once again for the ... This year the Surry Arts Council will be celebrating its 25th ... who are still fans of the Andy Griffith Show. ... on CBS from 1960 through 1968. The show ranked by ... Mount Airy, North Carolina is where the show was filmed ...
(Date:9/20/2014)... September 20, 2014 Earlier this week, Home ... may have had their credit card information pilfered by hackers, ... a slew of headline articles like this one ... only eye opening numbers. , “Most people tend to ... like it’s a way to score a game,” says Joe ...
(Date:9/20/2014)... 2014 The first federal bellwether trial ... its third week in the U.S. District Court, Northern ... documents indicate that the week opened in the ... a DePuy Orthopaedics vice president, who discussed the clinical ... Pinnacle hip replacement. According to Reuters, the executive stated ...
(Date:9/19/2014)... 2014 Consistent premium price increases ... Vision Insurance industry in recent years; however, costs ... industry margins. From 2009 to 2014, industry revenue ... coverage for routine eye exams and other procedures, ... lens and refractive surgery. According to IBISWorld Industry ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 3Health News:Mayberry Days Parade Cars will be Provided by Mount Airy Toyota and Mount Airy Chrysler Dodge Jeep Ram 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 4
... symptoms of grief linger and become increasingly debilitating. This ... and post-traumatic stress disorder (PTSD). // And there ... may bring relief, reports the October issue of the ... symptoms of complicated grief are intrusive thoughts of the ...
... the South Australian Government’s decision to review the types of ... SA Government says it’s concerned that chips, lollies, chocolate and ... vending machines and canteens. ,Dr Haikerwal said many ... ,“Hospitals should make healthy food the easy option,” ...
... staff working the night shift could benefit from a ... research has revealed. // ,In their editorial ... Professor Doug McEvoy and Professor Leon Lack of Flinders ... short periods of shut-eye for medical staff working through ...
... the University of Washington, in Seattle, a group of engineers ... latest creation: a surgical robot// to deploy in far-flung places, ... ,Military groups all over the world have long ... time often decides who lives and who dies. A recent ...
... Children's Research Hospital have discovered that a protein called ABCB6 ... is key to the ability// of red blood cells to ... of cells to extract energy from nutrients. ,The ... outer membrane of the cell’s energy powerhouse called the mitochondria; ...
... the good news: Suicide rates among younger and older Americans ... news: No one really knows why// . ,Those ... the University of South Carolina and released Thursday (Sept. 28) ... Health. ,Dr. Robert McKeown, a professor and associate ...
Cached Medicine News:Health News:Power Naps to Fight Night-shift Fatigue 2Health News:Doc at a Distance 2Health News:ABCB6 Is Key to Production of Heme in Hemoglobin 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 3
... is synthesized in the parafollicular C-cells of ... secretory granules. The major action of calcitonin ... inhibiting osteoclast activity, resulting in decreased mobilization ... is most evident in conditions associated with ...
... test provides a method for the lay user ... is comprised of a plastic probe with pH ... a package insert. The plastic probe is in ... is indicated for measuring vaginal pH for the ...
... The Rapidlab 1200's speed and accuracy ... decisions in a timely manner - ... value, especially patients. In fact, the ... parameters in just one minute. Its ...
Dornier Holmium Laser for Urological Procedures...
Medicine Products: